Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression

Teratology
G L BarnesR S Tuan

Abstract

The repeated pattern of the axial skeleton results from the segmentation and re-segmentation of the mesodermally derived somites. During these early events of somite development, the vertebrate embryonic axial skeleton is most susceptible to the teratogenic effects of a variety of pharmaceutical and environmental agents. One example is the anticonvulsant drug valproic acid (VPA), which has been shown to cause craniofacial and minor and major skeletal defects in human and animal embryos. We hypothesize that a candidate set of molecular targets of teratogens are the Pax family of pattern-forming genes, specifically Pax-1, which has been previously demonstrated to be an important regulator of axial skeletal patterning at the somite level. In this study, early developmental stage chick embryos were treated with VPA and dose-dependent malformations in somite development were observed. Two classes of anomalies were evident: class I included discrete sites of somitic fusions or mis-segmentation, and Class II included large areas of disorganized somite patterning. Northern blot analysis revealed a decreased level of Pax-1 expression in VPA-treated embryos. Whole mount in situ hybridization analysis showed that somite anomalies correlat...Continue Reading

References

Sep 6, 1991·Cell·G ChalepakisP Gruss
Mar 15, 1986·Biochemical Pharmacology·M E Coakley, N A Brown
Jun 1, 1987·Teratology·E J LammerG P Oakley
May 1, 1987·The Journal of Cell Biology·J L DubandJ P Thiery
Feb 1, 1986·Teratology·G C Vedel-Macrander, R D Hood
Feb 28, 1985·The New England Journal of Medicine·D J Dalessio
Nov 1, 1984·The Journal of Experimental Zoology·J W LashD Ostrovsky
Aug 5, 1984·Nature·R J Keynes, C D Stern
Apr 1, 1994·Anatomy and Embryology·P P Tam, P A Trainor
Oct 1, 1996·Differentiation; Research in Biological Diversity·G L BarnesR S Tuan
Dec 1, 1962·The Journal of Experimental Zoology·R RUGH, M WOHLFROMM
Jan 1, 1951·Journal of Morphology·V HAMBURGER, H L HAMILTON

❮ Previous
Next ❯

Citations

May 9, 2009·Neurological Research·Mohammad Taghi GhorbanianYaghoub Fathollahi
Mar 1, 2013·Spine·Jennifer HesemannPhilip F Giampietro
May 9, 2006·Neurosurgical Focus·M C SpeerT H Milhorat
Dec 25, 2007·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Rochelle W TylJohn M Rogers
Apr 8, 2015·Colloids and Surfaces. B, Biointerfaces·Agnese BlandinoLuca Santi
Aug 24, 2016·Anatomical Science International·Juramt BoldYoshihiro Fukui
Feb 27, 2001·Teratogenesis, Carcinogenesis, and Mutagenesis·R PennatiC Sotgia
Feb 25, 1999·Developmental Dynamics : an Official Publication of the American Association of Anatomists·E E LeClairR S Tuan
May 30, 2003·European Journal of Human Genetics : EJHG·J M McGaughranM Tassabehji
Jun 15, 2010·Birth Defects Research. Part C, Embryo Today : Reviews·Peter G Alexander, Rocky S Tuan
Aug 4, 2019·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·U TurgutA Ozak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.